Pre-made Ansuvimab benchmark antibody ( Whole mAb, anti-Zaire Ebolavirus GP1 therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-028

Pre-Made Ansuvimab biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP1 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Ansuvimab, sold under the brand name Ebanga, is a monoclonal antibody medication for the treatment of Zaire ebolavirus (Ebolavirus) infection.

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package List Price(In USD) Discount off Discount Price
GMP-Bios-ab-028-1mg 1mg 3090 30% 2163

Size: 1mg | 10mg | 100mg



Description

Products Name (INN Index) Pre-Made Ansuvimab biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP1 therapeutic antibody
INN Name Ansuvimab
TargetZaire Ebolavirus GP1
FormatWhole mAb
Derivation
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Approved
Est. StatusActive
100% SI StructureNone
99% SI Structure5fha:HL/5fhc:HL
95-98% SI StructureNone
Year Proposed2020
Year Recommendedna
CompaniesRidgeback Biotherapeutics
Conditions ApprovedZaire ebolavirus infection
Conditions Activena
Conditions Discontinuedna
Development Techna